Carolyn Crist March 09, 2023 Metformin appears to play a role in preventing long COVID when taken early during a COVID-19 infection, according to a new preprint study from The Lancet. The preprint hasn’t yet been peer-reviewed or published in a journal. In particular, metformin led to a 42% drop in long COVID among people who had a mild to...
Megan Brooks February 16, 2023 Treatment with the thiazolidinedione pioglitazone may offer the greatest protection against dementia for older adults with newly diagnosed type 2 diabetes mellitus (T2DM) who have a history of stroke or ischemic heart disease, new research suggests. Overall, in a large cohort study from Korea, patients who took pioglitazone were 16% less likely to develop dementia over an...
by Monash University Incidence of major adverse cardiovascular events (MACE) in men and women dispensed either a sodium glucose co-transporter 2 inhibitor (SGLT2i) or glucagon-like peptide receptor 1 agonist (GLP-1RA) 60-days after their index discharge date. Follow up of people is until 30th June 2018. Symbols on curves indicate competing risk events (i.e. non-MACE related...
by Lisa M. Krieger, The Mercury News Credit: CC0 Public Domain Is an ancient compound the new “wonder drug”? Metformin, a common medication to control diabetes, has become the controversial darling of tech’s health-conscious digerati who are enticed by preliminary research suggesting it might help promote longevity, reduce dementia and prevent a whole host of other conditions—including,...
By Elaine ChenDec. 7, 2022 Reprints PATRICK SISON/AP Touted by celebrities, raved about by TikTok users, and advertised by med spas, a new class of drugs for treating diabetes and obesity has exploded in popularity for its weight-loss effects, leading to rippling shortages across several of the medications. Amid the surge in demand, Eli Lilly and...
By Raghav Mahobe and Nandhini Srinivasan Nov 18 (Reuters) – Provention Bio Inc (PRVB.O) has priced its diabetes drug teplizumab at $13,850 a vial, it said on Friday, a day after receiving U.S. approval and far higher than some analysts’ expectations. The company’s shares reversed course from premarket gains to trade down nearly 12% as the high pricing stoked fears...
CLEVELAND CLINIC October 11, 2022, CLEVELAND: Cleveland Clinic researchers have identified a common diabetes medication, metformin, as a possible treatment for atrial fibrillation. The study, published in Cell Reports Medicine, built on ongoing collaborative Cleveland Clinic research to support further investigation into metformin as a drug repurposing candidate. Researchers used advanced computation and genetic sequencing...
by Karolinska Institutet Credit: Pixabay/CC0 Public Domain Mechanisms associated with a particular diabetes drug can also help to protect against Alzheimer’s disease, a study by researchers at Karolinska Institutet in Sweden and published in Neurology reports. The results indicate that the drug’s target protein could be an interesting candidate for the treatment of Alzheimer’s disease. Alzheimer’s disease...
Jonathan Gardner Senior Reporter Eli Lilly & Co. The Food and Drug Administration on Friday approved Eli Lilly’s diabetes drug Mounjaro, a first-of-its-kind treatment that can help control patients’ blood sugar and, potentially, help them lose weight as well. Mounjaro, also known as tirzepatide, expands Lilly’s diabetes business, which includes insulins as well as other...
According to a new study by Stanford Medicine investigators and their collaborators in Denmark, boys were more likely to be born with genital birth defects if their fathers took the commonly prescribed diabetes drug metformin three months before conception. The finding adds to a limited but growing understanding of how paternal factors can affect children’s health. “For...
